20 June 2013
Keywords: archimedes, reports, strong, data, drugs, uk-based, pharma
Article | 02 March 2009
UK-based Archimedes Pharma has reported positive data from two Phase I proof-of-principle trials for its intranasal apomorphine and diazepam
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 March 2009
19 June 2013
© 2013 thepharmaletter.com